Abbott Labs board OKs $7 billion stock buyback program
Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was approved by Abbott’s board of directors this month, the North Chicago-based company announced today in conjunction with revealing its third-quarter earnings.
US companies boosted their stock buyback plans this year, amidrising profits and excess cash. According to data from EPFR, ...
The board of Ulta Beauty has approved a $3 billion share repurchase authorization as it prepares to open 200 net new stores over the next three years. The specialty cosmetics retailer said Wednesday ...
China’s central bank has kicked off a specialized re-lending facility for listed companies and major shareholders to buy back shares, a move to boost capital markets as part of a broad stimulus ...
Buybacks are popular in a hot stock market as concerns about a potential increase to the 1% buyback tax heat up Companies have been feverishly announcing plans to buy back their own stock this ...
H&R Block is a strong investment choice with share repurchases, growth potential, and a solid reputation for professional tax ...
The Winnipeg, Manitoba-based packaging solutions said Thursday that the Toronto Stock Exchange has accepted the amendment to increase the maximum number of shares it can repurchase under its current ...
City Hall may have disqualified itself from getting millions in federal housing dollars. Crain’s residential real estate ...
Hosted on MSN40m
Asian stocks rise after China GDP, buyback details: markets wrapAsian equities rose as investors digested China’s better-than-expected economic data and a brightened outlook for chipmakers following Taiwan Semiconductor Manufacturing Co.’s earnings.
Microsoft recently announced a stock buyback and dividend hike. Does this news make MSFT stock a potential buy?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback